Quick Answer
PLIANT THERAPEUTICS, INC. reported Long-Term Debt of $0.00 for fiscal year 2025.
PLIANT THERAPEUTICS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $30.21M | +200.5% |
| 2023 | $10.05M | +1.3% |
| 2022 | $9.93M | — |
| 2021 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.44M | +1.0% | +0.3% |
| June 30, 2025 | $30.36M | +1.0% | +0.3% |
| March 31, 2025 | $30.28M | +0.9% | +0.2% |
| December 31, 2024 | $30.21M | +200.5% | +0.2% |
| September 30, 2024 | $30.14M | +200.8% | +0.2% |
| June 30, 2024 | $30.07M | +201.1% | +0.2% |
| March 31, 2024 | $30.00M | +201.3% | +198.4% |
| December 31, 2023 | $10.05M | +1.3% | +0.3% |
- PLIANT THERAPEUTICS, INC. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from PLIANT THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: